These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 8415878

  • 1. Clinical pharmacology of corticosteroids in bronchial asthma.
    Lipworth BJ.
    Pharmacol Ther; 1993; 58(2):173-209. PubMed ID: 8415878
    [Abstract] [Full Text] [Related]

  • 2. Comparative efficacy and safety of inhaled corticosteroids in asthma.
    Jackson LD, Polygenis D, McIvor RA, Worthington I.
    Can J Clin Pharmacol; 1999; 6(1):26-37. PubMed ID: 10465863
    [Abstract] [Full Text] [Related]

  • 3. Dose-response of inhaled drugs in asthma. An update.
    Clark DJ, Lipworth BJ.
    Clin Pharmacokinet; 1997 Jan; 32(1):58-74. PubMed ID: 9012556
    [Abstract] [Full Text] [Related]

  • 4. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ.
    Arch Intern Med; 1999 May 10; 159(9):941-55. PubMed ID: 10326936
    [Abstract] [Full Text] [Related]

  • 5. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
    Selroos O, Halme M.
    Thorax; 1991 Dec 10; 46(12):891-4. PubMed ID: 1792636
    [Abstract] [Full Text] [Related]

  • 6. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.
    Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS.
    Drugs; 1975 Dec 10; 10(3):166-210. PubMed ID: 172309
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroid therapy with nebulized beclometasone dipropionate.
    Nicolini G, Cremonesi G, Melani AS.
    Pulm Pharmacol Ther; 2010 Jun 10; 23(3):145-55. PubMed ID: 19961948
    [Abstract] [Full Text] [Related]

  • 8. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT, Richards DH.
    Clin Ther; 2004 Nov 10; 26(11):1905-19. PubMed ID: 15639702
    [Abstract] [Full Text] [Related]

  • 9. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
    Kramer S, Rottier BL, Scholten RJ, Boluyt N.
    Cochrane Database Syst Rev; 2013 Feb 28; (2):CD010352. PubMed ID: 23450613
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
    Arch Dis Child; 1993 Aug 28; 69(2):206-11. PubMed ID: 8215522
    [Abstract] [Full Text] [Related]

  • 11. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B, Faulds D.
    Drugs; 1999 May 28; 57(5):769-803. PubMed ID: 10353302
    [Abstract] [Full Text] [Related]

  • 12. Safety of the newer inhaled corticosteroids in childhood asthma.
    Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP.
    Paediatr Drugs; 2003 May 28; 5(7):481-504. PubMed ID: 12837120
    [Abstract] [Full Text] [Related]

  • 13. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma.
    Barnes PJ.
    J Allergy Clin Immunol; 1998 Apr 28; 101(4 Pt 2):S427-33. PubMed ID: 9563367
    [Abstract] [Full Text] [Related]

  • 14. Inhaled corticosteroids in children with asthma: pharmacologic determinants of safety and efficacy and other clinical considerations.
    Gulliver T, Morton R, Eid N.
    Paediatr Drugs; 2007 Apr 28; 9(3):185-94. PubMed ID: 17523699
    [Abstract] [Full Text] [Related]

  • 15. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
    Lipworth BJ, Clark DJ, McFarlane LC.
    Thorax; 1997 Aug 28; 52(8):686-9. PubMed ID: 9337826
    [Abstract] [Full Text] [Related]

  • 16. Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis.
    Clissold SP, Heel RC.
    Drugs; 1984 Dec 28; 28(6):485-518. PubMed ID: 6394263
    [Abstract] [Full Text] [Related]

  • 17. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids.
    Brown PH, Blundell G, Greening AP, Crompton GK.
    Respir Med; 1991 Nov 28; 85(6):501-10. PubMed ID: 1775677
    [Abstract] [Full Text] [Related]

  • 18. Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma.
    Ninan TK, Reid IW, Carter PE, Smail PJ, Russell G.
    Thorax; 1993 Jun 28; 48(6):599-602. PubMed ID: 8346487
    [Abstract] [Full Text] [Related]

  • 19. Once-daily inhaled corticosteroids in mild to moderate asthma: improving acceptance of treatment.
    Campbell LM.
    Drugs; 1999 Jun 28; 58 Suppl 4():25-33; discussion 52. PubMed ID: 10711856
    [Abstract] [Full Text] [Related]

  • 20. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma.
    Sharpe M, Jarvis B.
    Drugs; 2001 Jun 28; 61(9):1325-50. PubMed ID: 11511026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.